Evaluation of the protective effect of the intranasal vaccines adjuvanted with bacterium-like particles against intestinal infection
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Oral Vaccination with Hepatitis E Virus Capsid Protein and Immunobiotic Bacterium-Like Particles Induce Intestinal and Systemic Immunity in MiceProbiotics and Antimicrobial Proteins, 2019
- Polio endgame: Lessons for the global rotavirus vaccination programVaccine, 2019
- Intranasal co-administration of recombinant active fragment of Zonula occludens toxin and truncated recombinant EspB triggers potent systemic, mucosal immune responses and reduces span of E. coli O157:H7 fecal shedding in BALB/c miceMedical Microbiology and Immunology, 2018
- Humoral Immunity in the Gut Selectively Targets Phenotypically Virulent Attaching-and-Effacing Bacteria for Intraluminal EliminationCell Host & Microbe, 2015
- Inactivated influenza vaccine adjuvanted with Bacterium-like particles induce systemic and mucosal influenza A virus specific T-cell and B-cell responses after nasal administration in a TLR2 dependent fashionVaccine, 2014
- Gastro-intestinal delivery of influenza subunit vaccine formulation adjuvanted with Gram-positive enhancer matrix (GEM) particlesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2010
- Development of lactococcal GEM-based pneumococcal vaccinesVaccine, 2007
- The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper CellsCell, 2006
- Secretory ComponentImmunity, 2002
- Enteropathogenic E. coli (EPEC) Transfers Its Receptor for Intimate Adherence into Mammalian CellsCell, 1997